Top

Published in:

Open Access 01-04-2014 | Review

Megabladder mouse model of congenital obstructive nephropathy: genetic etiology and renal adaptation

Author: Kirk M. McHugh

Published in: Pediatric Nephrology | Issue 4/2014

Abstract

Congenital obstructive nephropathy remains one of the leading causes of chronic renal failure in children. The direct link between obstructed urine flow and abnormal renal development and subsequent dysfunction represents a central paradigm of urogenital pathogenesis that has far-reaching clinical implications. Even so, a number of diagnostic, prognostic, and therapeutic quandaries still exist in the management of congenital obstructive nephropathy. Studies in our laboratory have characterized a unique mutant mouse line that develops in utero megabladder, variable hydronephrosis, and progressive renal failure. Megabladder mice represent a valuable functional model for the study of congenital obstructive nephropathy. Recent studies have begun to shed light on the genetic etiology of mgb ^−/− mice as well as the molecular pathways controlling disease progression in these animals.

Singh S, Robinson M, Nahi F, Coley B, Robinson M, Bates C, Kornacker K, McHugh KM (2007) Identification of a unique transgenic mouse line that develops megabladder, obstructive uropathy, and renal dysfunction. J Am Soc Nephrol 18:461–471PubMedCrossRef

Singh S, Robinson M, Ismail I, Saha M, Auer H, Kornacker K, Robinson M, Bates C, McHugh KM (2008) Transcriptional profiling of the megabladder mouse—a unique model of bladder dysmorphogenesis. Dev Dyn 237:170–186PubMedCrossRef

Greenfield S, Hensle T, Berdon W, Wigger H (1983) Unilateral vesicoureteral reflux and unilateral nonfunctioning kidney associated with posterior urethral valves–a syndrome? J Urol 130:733–738PubMed

Kousidis G, Thomas D, Morgan H, Haider N, Subramaniam R, Feather S (2008) The long-term outcome of prenatally detected posterior urethral valves: a 10 to 23-year follow-up study. BJU Int 102:1020–1024PubMedCrossRef

Sanna-Cherchi S, Ravani P, Corbani V, Parodi S, Haupt R, Piaggio G, Innocenti M, Somenzi D, Trivelli A, Caridi G, Izzi C, Scolari F, Mattioli G, Allegri L, Ghiggeri G (2009) Renal outcome in patients with congenital anomalies of the kidney and urinary tract. Kidney Int 76:528–533PubMedCrossRef

Ansari M, Gulia A, Srivastava A, Kapoor R (2010) Risk factors for progression to end-stage renal disease in children with posterior urethral valves. J Pediatr Urol 6:261–264PubMedCrossRef

Kleinjan D, Lettice L (2008) Long-range gene control and genetic disease. Advs Genet 61:340–388

Loots G, Kneissel M, Keller H, Baptist M, Chang J, Collette N, Ovcharenko D, Plajzer-Frick L, Rubin E (2005) Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchen disease. Gen Res 15:928–935CrossRef

Fukami M, Okuyama T, Yamamori S, Nishimura G, Ogata T (2005) Microdeletion in the SHOX3’ region associated with skeletal phenotypes of Langer mesomelic dysplasia in a 45, X/46, X, r(X) infant and Leri-Weill dyschondrosteosis in her 46, XX mother: implications for the SHOX enhancer. Am J Med Genet 137:72–76PubMedCrossRef

10.

Cai J, Goodman B, Patel A, Muliken J, Van Maldergem L, Hoganson G, Paznekas W, Ben Neriah Z, Sheiffer R, Cunningham M, Daentl D, Jabs E (2003) Increased risk for developmental delay in Saethre-Chotzen syndrome is associated with TWIST deletions: an improved strategy for TWIST mutation screening. Hum Genet 114:68–76PubMedCrossRef

11.

Bowl M, Nesbit M, Harding B, Levy E, Jefferson A, Volpi E, Rizzoti K, Lovell-Badge R, Schlessinger D, Whyte M, Thakker R (2005) An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3 causes X-linked recessive hypoparathyroidism. J Clin Invest 115:2822–2831PubMedCentralPubMedCrossRef

12.

Trembath GD, Semina EV, Jones DH, Patil SR, Qian Q, Amendt BA, Russo AF, Murray JC (2004) Analysis of two translocation breakpoints and identification of a negative regulatory element in patients with Rieger’s syndrome. Birth Defects Res Part A Clin Mol Teratol 70:82–91PubMedCrossRef

13.

Wild A, Kaliff-Suske M, Vortkamp A, Bornholdt D, Konig R, Grzeschik K (1997) Point mutations in human GLI3 cause Greig syndrome. Hum Mol Genet 6:1979–1984PubMedCrossRef

14.

De Kok Y, Vossenaar E, Cremers C, Dahl N, Laporte J, Hu L, Lacombe D, Fischel-Ghodsian N, Friedman R, Parnes L, Thorpe P, Bitner-Glindez M, Pander H, Heilbronner H, Graveline J, den Dunnen J, Brunner H, Ropers H, Cremers F (1996) Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. Hum Mol Genet 5:1229–1235PubMedCrossRef

15.

Becknell B, Carpenter A, Allen J, Wilhide M, Ingraham S, Hains D, McHugh KM (2013) Molecular basis of renal adaptation in a murine model of congenital obstructive nephropathy. PLoS One 8(9):e72762PubMedCentralPubMedCrossRef

16.

Ingraham S, Saha M, Carpenter A, Robinson M, Ismail I, Singh S, Hains D, Robinson M, Hirselj D, Koff S, Bates C, McHugh KM (2010) Pathogenesis of renal injury in the megabladder mouse: a genetic model of congenital obstructive nephropathy. Pediatr Res 68:500–507PubMedCentralPubMedCrossRef

17.

Inazaki K, Kanamaru Y, Kojima Y, Sueyoshi N, Okumura K, Kaneko K, Yamahiro Y, Igawa H, Nakao A (2004) Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int 66:597–604PubMedCrossRef

18.

Sato M, Muragaki Y, Saika S, Roberts A, Ooshima A (2003) Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112:1486–1494PubMedCentralPubMedCrossRef

19.

Furness P 3rd, Maizels M, Han S, Cohn R, Cheng E (1999) Elevated bladder urine concentration of transforming growth factor-beta1 correlates with upper urinary tract obstruction in children. J Urol 162:1033–1036PubMedCrossRef

20.

Merlet-Benichou C, Vilar J, Lelievre-Pegorier M, Gilbert T (1999) Role of retinoids in renal development: pathophysiological implication. Curr Opin Nephr Hypertens 8:39–43CrossRef

21.

Batourina E, Choi C, Paragas N, Bello N, Hensle T, Costantini F, Schuchardt A, Bacallao R, Mendelsohn C (2002) Distal ureter morphogenesis depends on epithelial cell remodeling mediated by vitamin A and Ret. Nat Genet 32:109–115PubMedCrossRef

22.

Kishimoto K, Kinoshita K, Hino S, Yano T, Nagare Y, Shimazu H, Nozaki Y, Sugiyama M, Ikoma S, Funauchi M (2011) Therapeutic effect of retinoic acid on unilateral ureteral obstruction model. Nephron Exp Nephrol 118:e69–e78PubMedCrossRef

23.

Schaier M, Jocks T, Grone H, Ritz E, Wagner J (2003) Retinoid agonist isotretinoin ameliorates obstructive renal injury. J Urol 170:1398–1402PubMedCrossRef

24.

Balasubramanian S, Jansen M, Valerius M, Humphreys B, Strom T (2012) Orphan nuclear receptor Nur77 promotes acute kidney injury and renal epithelial apoptosis. J Am Soc Nephrol 23:674–686PubMedCrossRef

25.

Scrocchi L, Hearn S, Han V, Hammond G (1993) Corticosteroid-binding globulin biosynthesis in the mouse liver and kidney during postnatal development. Endocrinology 132:910–916PubMed

26.

Dokmanovic M, Clarke C, Marks PA (2007) Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 5:981–989PubMedCrossRef

27.

Ingelfinger J, Woods L (2002) Perinatal programming, renal development, and adult renal function. Am J Hypertens 15:46S–49SPubMedCrossRef

28.

Si H, Banga R, Kapitsinou P, Ramaiah M, Lawrence J, Kambhampati G, Gruenwald A, Bottinger E, Glicklich D, Tellis V, Greenstein S, Thomas D, Pullman J, Fazzari M, Susziak K (2009) Human and murine kidneys show gender- and species-specific gene expression differences in response to injury. PLoS One 4:e4802PubMedCentralPubMedCrossRef

29.

Metcalfe P, Meldrum K (2006) Sex differences and the role of sex steroids in renal injury. J Urol 176:15–21PubMedCrossRef

30.

Hutchens M, Dunlap J, Hurn P, Jarnberg P (2008) Renal ischemia: does sex matter? Anaesth Analg 107:239–429CrossRef

31.

Seliger S, Davis C, Stehman-Breen C (2001) Gender and the progression of renal disease. Curr Opin Nephrol Hypertens 10:219–225PubMedCrossRef

32.

Reyes D, Lew S, Kimmel P (2005) Gender differences in hypertension and kidney disease. Med Clin North Am 89:613–630PubMedCrossRef

33.

Delle H, Rocha J, Cavaglieri R, Vieira J Jr, Malheiros D, Noronha I (2012) Antifibrotic effect of tamoxifen in a model of progressive renal disease. J Am Soc Nephrol 23:37–48PubMedCrossRef

34.

Metcalfe P, Leslie J, Campbell M, Meldrum D, Hile K, Meldrum K (2008) Testosterone exacerbates obstructive renal injury by stimulating TNF-alpha production and increasing proapoptotic and profibrotic signaling. Am J Physiol Endocrin Metab 294: E435–E443CrossRef

35.

Becknell B, Carpenter A, Bolon B, Ingraham S, Hains D, Schwaderer A, McHugh KM (2013) Struvite urolithiasis and pyelonephritis associated with cutaneous vesicostomy in a murine model of functional lower urinary tract obstruction. Urology 81:943–948PubMedCentralPubMedCrossRef

Title: Megabladder mouse model of congenital obstructive nephropathy: genetic etiology and renal adaptation
Author: Kirk M. McHugh
Publication date: 01-04-2014
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 4/2014
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-013-2658-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Megabladder mouse model of congenital obstructive nephropathy: genetic etiology and renal adaptation

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2014

Recreating kidney progenitors from pluripotent cells

Engineering kidneys from simple cell suspensions: an exercise in self-organization

Vesicoureteric reflux and reflux nephropathy: from mouse models to childhood disease

Urinary tract pacemaker cells: current knowledge and insights from nonrenal pacemaker cells provide a basis for future discovery

Polycystin-1 cleavage and the regulation of transcriptional pathways

Coordination of kidney organogenesis by Wnt signaling